Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots (Q34116690)

31 July 2017

title

Geneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots (English)

1 reference

31 July 2017

M Bosilkovska

1

1 reference

31 July 2017

C F Samer

2

1 reference

31 July 2017

J Déglon

3

1 reference

31 July 2017

M Rebsamen

4

1 reference

31 July 2017

C Staub

5

1 reference

31 July 2017

P Dayer

6

1 reference

31 July 2017

B Walder

7

1 reference

31 July 2017

J A Desmeules

8

1 reference

31 July 2017

Y Daali

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

10 April 2014

1 reference

Clinical Pharmacology & Therapeutics

31 July 2017

published in

1 reference

31 July 2017

volume

96

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

349-359

1 reference

Transporters and drug-drug interactions: important determinants of drug disposition and effects

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Dried blood spots and sparse sampling: a practical approach to estimating pharmacokinetic parameters of caffeine in preterm infants.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Application of dried blood spot sampling combined with LC-MS/MS for genotyping and phenotyping of CYP450 enzymes in healthy volunteers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Inhibition of CYP2D6 activity by bupropion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

The effect of rifampin administration on the disposition of fexofenadine

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5 1 cocktail".

5 July 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

A cytochrome P450 phenotyping cocktail causing unexpected adverse reactions in female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole, and posaconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healthy Japanese volunteers, using the cocktail method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Effect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2014.83

Predicting drug candidate victims of drug-drug interactions, using microdosing

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4151019

Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine

28 October 2018

2 references

12 December 2020

https://api.crossref.org/works/10.1038/CLPT.2014.83

7 January 2021

inferred from DOI database lookup

Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations

1 reference

12 December 2020

Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of bupropion administered to human volunteers

1 reference

12 December 2020

Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine

1 reference

12 December 2020

Validation of incorporating flurbiprofen into the Pittsburgh cocktail

1 reference

12 December 2020

Pharmacokinetic Considerations as to When to Use Dried Blood Spot Sampling

1 reference

12 December 2020

Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot

1 reference

12 December 2020

Incorporation of flurbiprofen in a 4-drug cytochrome p450 phenotyping cocktail

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2014.83

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference